Ozmosi | Zirconium silicate Drug Profile
Drug Search Results
Using advanced filters...
Advanced Search [+]

Zirconium silicate

Alternative Names: zirconium silicate
Clinical Status: Inactive
Latest Update: 2025-11-04
Latest Update Note: News Article

Product Description

Mechanisms of Action: Radioactive Agent

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: ZS Pharma
Company Location:
Company CEO:
Additional Commercial Interests: None

Clinical Description

Countries in Clinic:

Active Clinical Trial Count:

Recent & Upcoming Milestones

Highest Development Phases

Phase 3: Hyperkalemia

Phase 2: Kidney Failure, Chronic|Hyperkalemia

Trial ID

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Latest Trial Update Date

Data Updated

NCT01493024

ZS-002

P2

Completed

Hyperkalemia|Kidney Failure, Chronic

2012-05-31

2019-03-19

Treatments

NCT02088073

ZS-004

P3

Completed

Hyperkalemia

2014-08-31

2019-03-20

Treatments

NCT01737697

ZS-003

P3

Completed

Hyperkalemia

2013-10-31

2019-03-19

Treatments